WB, IP
H
Endogenous
78
Rabbit IgG
#Q9C0B5
25921
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
| Immunoprecipitation | 1:50 |
Storage
Specificity / Sensitivity
Species Reactivity:
Human
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu330 of human ZDHHC5 protein.
Background
Zinc finger DHHC domain-containing protein 5 (ZDHHC5) is a multipass membrane protein that is localized predominantly at the plasma membrane and endosomal compartment membranes (1). ZDHHC5 belongs to a large family of enzymes known as palmitoyl-acyltransferases. Using long-chain fatty acids such as palmitic acid, ZDHHC5 catalyzes the reversible, post-translational modification of cysteine residues within protein substrates to regulate their trafficking and subcellular localization (1,2). Research studies have shown that ZDHHC5 is itself regulated by multiple types of post-translational modifications, such as phosphorylation and palmitoylation, which regulate its subcellular localization and enzymatic activity (3,4). Palmitoylation mediated by ZDHHC5 plays a role in the host response to pathogens. Indeed, ZDHHC5-mediated palmitoylation of NOD1/2 pattern recognition receptors facilitates their correct localization to endosomal vesicle membranes containing internalized bacteria in order to initiate innate immune signaling cascades (5). Furthermore, ZDHHC5 was recently shown to interact with SARS-CoV-2 spike protein. This interaction is posited to facilitate S-acylation of the spike protein and fusion with host cell membranes (6,7).
- Ohno, Y. et al. (2006) Biochim Biophys Acta 1761, 474-83.
- Korycka, J. et al. (2012) Eur J Cell Biol 91, 107-17.
- Hao, J.W. et al. (2020) Nat Commun 11, 4765.
- Woodley, K.T. and Collins, M.O. (2019) EMBO Rep 20, e47472.
- Lu, Y. et al. (2019) Science 366, 460-467.
- Gordon, D.E. et al. (2020) Nature 583, 459-468.
- Wu, Z. et al. (2021) Signal Transduct Target Ther 6, 231.
Species Reactivity
Species reactivity is determined by testing in at least one approved application (e.g., western blot).
Western Blot Buffer
IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.
Applications Key
WB: Western Blotting IP: Immunoprecipitation
Cross-Reactivity Key
H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.